ப்ராடக்ட் காப்புரிமைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ராடக்ட் காப்புரிமைகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ராடக்ட் காப்புரிமைகள் Today - Breaking & Trending Today

Humanity matters, capitalism needs an upgrade

The COVID-19 vaccine crisis is an opportune time when companies must rethink the purpose behind their existence ....

South Africa , South African , Varun Maira , Mariana Mazzucato , Wolfgang Streeck , Garrett Hardin , World Trade Organization , Will Capitalism , Ask Wolfgang Streeck , Trade Related Aspects , Intellectual Property Rights , Billion Fireflies , Critical Conversations , New Post Pandemic , Covid 19 Vaccine Crisis , Clash Between The Needs Of Humanity And Principles Capitalism , Private Producers Of Vaccines , Research And Production , Beyond The Reach Of Poor People , Private Producers , Subsidise Sales , Taxes On Private Companies , Private Companies , Governments For Lower Taxes , Attractive Investments , Ideological Grounds ,

WTO versus Humankind?

WTO versus Humankind?
Bharat Jhunjhunwala
In the main two vaccines are available to us today Covishield developed by AstraZeneca and produced under its license by Serum Institute of India; and Covaxin developed by Bharat Biotech. Serum Institute has to pay one-half of the sale price to AstraZeneca as royalty; or it has to pay Rs 75 as royalty if it sells Covishield to the Central Government at Rs 150. Serum Institute says that it is not economic for it to produce Covishield in the balance Rs 75. For this reason, they have offered to sell Covishield only at Rs 300 to the States and at a higher price to the private buyers. In this way the States will be buying Covishield at Rs 300 and subsidizing the purchase by Center at Rs 150. The Center should act as father of the States. Instead it is acting as their opponent. This is a minor problem, however. Serum Institute is having to pay this huge amount of royalty because we have accepted Product Patents under the World Trade Orga ....

United States , Bharat Jhunjhunwala , World Trade Organization , Tv Program , Drug Companies , Indian Company Bharat Biotech , Serum Institute , Serum Institute Of India , Center At Rs , Central Government , Product Patents , Process Patents , Bharat Biotech , Multinational Corporations , Developed Countries , Formerly Professor , ஒன்றுபட்டது மாநிலங்களில் , பாரத் ஜுன்ஜுன்வாலா , உலகம் வர்த்தகம் ஆர்கநைஸேஶந் , தொலைக்காட்சி ப்ரோக்ர்யாம் , மருந்து நிறுவனங்கள் , சீரம் நிறுவனம் , சீரம் நிறுவனம் ஆஃப் இந்தியா , மைய அரசு , ப்ராடக்ட் காப்புரிமைகள் , பாரத் பயோடெக் ,

A Comprehensive Study Exploring Patent Medicine Market | Key Players Novartis, Otsuka Pharmaceutical, Pfizer, Merck

A Comprehensive Study Exploring Patent Medicine Market | Key Players Novartis, Otsuka Pharmaceutical, Pfizer, Merck
iCrowd Newswire
06 May 2021, 20:08 GMT+10
A new business intelligence report released by HTF MI with title Global Patent Medicine Market Growth (Status and Outlook) 2021-2026 is designed covering micro level of analysis by manufacturers and key business segments. The Global Patent Medicine Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and quantitative detailing. Some of the key players profiled in the study are Pfizer Inc., Otsuka Pharmaceutical, Merck, Novartis, Sanofi-Aventis, Bristol-Myers Squibb Co. & GSK. ....

United States , United Kingdom , South Africa , Products Of Major Companies , Research Study , Market Intelligence Consulting Private , See Campaign , Research Newswire , Pfizer Inc , Bristol Myers Squibb Co , Major Companies List , Patent Medicine , Patent Medicine Market Growth , Global Patent Medicine Market , Otsuka Pharmaceutical , Bristol Myers Squibb , Sample Report , All Related Graphs , Global Patent Medicine , Product Types , Study Explore , Patent Medicine Market , Product Patents , Southeast Asia , Middle East , Detailed Index ,